Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A genetically heterogeneous condition, typically inherited in an autosomal recessive fashion, characterized by coenzyme Q10 deficiency.
Biomarker and diagnostic research for coenzyme Q10 deficiency has been reported in the published literature.
No approved treatments are currently available for coenzyme Q10 deficiency. An additional 3 compounds hold orphan drug designation.
While no drugs are FDA-approved specifically for coenzyme Q10 deficiency, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.
The following drugs have received orphan drug designation from the FDA for coenzyme Q10 deficiency. Orphan designation reflects regulatory interest and does not indicate approval for treatment.
Brand Name | Generic Name | Sponsor |
|---|
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
67 publications have been identified in PubMed for coenzyme Q10 deficiency. Research spans Case Report / Case Series (43%), Basic Science / Preclinical (31%), and Review / Meta-Analysis (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 29 | 43% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:53 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about coenzyme Q10 deficiency
Designated
Exclusivity End |
|---|
Designation Status |
|---|
4-hydroxybenzoic acid | 4-hydroxybenzoic acid | University of Granada | 2026 | — | Designated |
4-hydroxybenzoate | 4-hydroxybenzoate | Gleeson Lab - UCSD | 2026 | — | Designated |
coenzyme Q10 (CoQ10) | coenzyme Q10 (CoQ10) | BPGbio Inc. | 2026 | — | Designated |
Gene therapy approaches for coenzyme Q10 deficiency have been reported in the published literature.
1 trial found
Laboratory research |
21 |
31% |
Research summaries | 6 | 9% |
Disease patterns and progression | 4 | 6% |
Clinical study results | 3 | 4% |
Testing and diagnosis research | 2 | 3% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Motoi H (2026). [PMID: 41769026](https://pubmed.ncbi.nlm.nih.gov/41769026/). *Case reports in neurology*. [Case Report / Case Series]
Hahn W (2026). [PMID: 41716779](https://pubmed.ncbi.nlm.nih.gov/41716779/). *Molecular genetics and metabolism reports*. [Case Report / Case Series]
Gavric AU (2026). [PMID: 42206750](https://pubmed.ncbi.nlm.nih.gov/42206750/). *Ocul Immunol Inflamm*. [Case Report / Case Series]
Klaučo F (2026). [PMID: 42073991](https://pubmed.ncbi.nlm.nih.gov/42073991/). *Int J Mol Sci*. [Basic Science / Preclinical]
Mantle D (2026). [PMID: 42074169](https://pubmed.ncbi.nlm.nih.gov/42074169/). *Int J Mol Sci*. [Review / Meta-Analysis]
Srinivasan VM (2026). [PMID: 42087660](https://pubmed.ncbi.nlm.nih.gov/42087660/). *Neurol India*. [Case Report / Case Series]
Watanabe C (2026). [PMID: 41468707](https://pubmed.ncbi.nlm.nih.gov/41468707/). *Brain & development*. [Epidemiology / Natural History]
Ökçesiz İ (2026). [PMID: 41528494](https://pubmed.ncbi.nlm.nih.gov/41528494/). *Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology*. [Case Report / Case Series]
Aristizabal-Henao JJ (2026). [PMID: 41931022](https://pubmed.ncbi.nlm.nih.gov/41931022/). *FASEB J*. [Basic Science / Preclinical]
Reddy SB (2026). [PMID: 41992454](https://pubmed.ncbi.nlm.nih.gov/41992454/). *Ann Afr Med*. [Case Report / Case Series]